文献速递妇科

腹壁子宫内膜异位症的手术与经皮影像引导治疗:当前证据的系统综述

Surgical and Percutaneous Image-Guided Therapies of Abdominal Wall Endometriosis: A Systematic Review of Current Evidence.
PubMed 文献 · J Minim Invasive Gynecol · 2024-06-18

本系统综述纳入51篇文献、共2674例腹壁子宫内膜异位症患者,其中2219例(83%)接受手术、455例(17%)接受经皮介入(高强度聚焦超声342例、冷冻消融103例、射频消融1例、微波消融9例)。手术组局部肿瘤控制率中位数100%、局部疼痛缓解率中位数98.2%(95%CI:93.9-97.7);高强度聚焦超声分别为95.65%(95%CI:87.7-99.9)和76.1%(95%CI:61.8-90.4);冷冻消融分别为85.7%(95%CI:66.0-99.9)和79.2%(95%CI:67.4-91.03)。作者认为非手术介入的安全性和疗效支持其临床用于腹壁子宫内膜异位症的管理。

要点

  • 手术组局部肿瘤控制率中位数100%,局部疼痛缓解率中位数98.2%(95%CI:93.9-97.7)。
  • 高强度聚焦超声局部肿瘤控制率中位数95.65%(95%CI:87.7-99.9),局部疼痛缓解率中位数76.1%(95%CI:61.8-90.4)。
  • 非手术介入的安全性和疗效支持其用于腹壁子宫内膜异位症的临床管理。

核心结论

  • 非手术介入的安全性和疗效支持其用于腹壁子宫内膜异位症的临床管理。

研究设计与样本

  • 系统综述,检索PubMed、Embase和Cochrane Library数据库自1947年至2023年12月的文献,注册于NIHR-PROSPERO(CRD 42023494969)。
  • 共纳入51篇文章(共识别831篇),所有研究设计均符合纳入标准。
  • 共纳入2674例患者:2219例(83%)接受手术,455例(17%)接受经皮介入(高强度聚焦超声342例、冷冻消融103例、射频消融1例、微波消融9例)。
  • 随访时间中位数18个月,范围1至235个月。

主要发现

  • 总体局部肿瘤控制率范围为86%至100%。
  • 手术干预的局部肿瘤控制率中位数100%,局部疼痛缓解率中位数98.2%(95%CI:93.9-97.7)。
  • 高强度聚焦超声的局部肿瘤控制率中位数95.65%(95%CI:87.7-99.9),局部疼痛缓解率中位数76.1%(95%CI:61.8-90.4)。
  • 冷冻消融的局部肿瘤控制率中位数85.7%(95%CI:66.0-99.9),局部疼痛缓解率中位数79.2%(95%CI:67.4-91.03)。
  • 手术后轻度不良事件发生于17.5%的患者(225/1284),其中15.9%(199/1284)为补片植入;高强度聚焦超声后为76.4%(239/313);冷冻消融后为8.7%(9/103);严重不良事件手术组25例、经皮介入组1例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite various surgical and nonsurgical strategies for abdominal wall endometriosis, the lack of definitive guidance on optimal treatment choice leads to clinical uncertainty. This review scrutinizes the safety and efficacy of abdominal wall endometriosis treatments to aid in decision-making. DATA SOURCES: We performed a systematic literature review of PubMed, Embase, and Cochrane Library databases from 1947 until December 2023. METHODS OF STUDY SELECTION: A comprehensive literature search identified studies that assessed both surgical and nonsurgical interventions, including high-intensity focused ultrasound (HIFU), cryoablation, radiofrequency ablation, and microwave ablation. This review is registered in NIHR-PROSPERO (CRD 42023494969). Local tumor control (LTC), local pain relief (LPR), and adverse events (AE) were recorded. TABULATION, INTEGRATION, AND RESULTS: This review included 51 articles among 831 identified. All study designs were considered eligible for inclusion. A total of 2674 patients are included: 2219 patients (83%) undergoing surgery, and 455 (17%) undergoing percutaneous interventions (342 HIFU, 103 cryoablation, 1 radiofrequency ablation, 9 microwave ablation). Follow-up length was 18 months in median, ranging from 1 to 235 months. Overall LTC rates ranged from 86% to 100%. Surgical interventions consistently demonstrated the highest rate of LTC with a median rate of 100%, and LPR with a median rate of 98.2% (95% confidence interval [CI]: 93.9-97.7). HIFU showed median LTC and LPR rates, respectively of 95.65% (95% CI, 87.7-99.9) and 76.1% (95% CI, 61.8-90.4); and cryoablation of 85.7% (95% CI, 66.0-99.9) and 79.2% (95% CI, 67.4-91.03). Minor AE was reported after surgery in 17.5% of patients (225/1284) including 15.9% (199/1284) of mesh implantation; 76.4% (239/313) after HIFU; and 8.7% (9/103) after cryoablation. Severe AE was reported in 25 patients in the surgery group and 1 in the percutaneous group. CONCLUSION: The safety profile and efficacy of nonsurgical interventions support their clinical utility for management of abdominal wall endometriosis.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Razakamanantsoa L, Bodard S, Najdawi M, et al. Surgical and Percutaneous Image-Guided Therapies of Abdominal Wall Endometriosis: A Systematic Review of Current Evidence. J Minim Invasive Gynecol. 2024. PMID: 38901689. doi:10.1016/j.jmig.2024.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。